Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WA › Seattle › NPI 1316983158
Lab

Quest Diagnostics Clinical Laboratories INC

Quest Diagnostics Clinical Laboratories INC was paid $109.23M by Medicaid between Jan 2018 and Dec 2024, across 486 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 7.7% of everything it billed.

33Billing provider infoQUEST DIAGNOSTICS CLINICAL LABORATORIES INC
SEATTLE, WA 98134
33aNPI1316983158assigned 06/21/2006
33bProvider typeClinical Medical Laboratory
28Total paid$109.23M
24GClaims9,197,808
24DCodes billed486
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Washington

Rank by total paid#2 of 76
Median peer was paid$90K
This provider vs. median1,208×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official BOWLES, CHARLES controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,175,567$11.53M
20191,371,326$14.44M
20201,059,156$13.00M
20211,347,617$18.26M
20221,406,705$18.49M
20231,463,428$16.63M
2024incomplete1,374,009$16.87M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 7.7% 119,947 113,126 $8.46M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 4.8% 213,985 203,443 $5.27M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 4.8% 214,266 203,751 $5.25M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 4.6% 11,970 10,262 $5.02M
80050 General health panel 4.4% 210,016 205,499 $4.76M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 4.1% 77,344 62,811 $4.50M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4.1% 119,197 92,414 $4.48M
80053 Comprehensive metabolic panel 3.1% 563,818 533,741 $3.44M
80061 Lipid panel 3.1% 421,328 407,298 $3.39M
84443 Thyroid stimulating hormone (TSH) 2.7% 317,925 307,147 $2.94M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.4% 169,320 165,332 $2.66M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.9% 460,928 427,754 $2.04M
474 more codes
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 1.7% 37,115 $1.81M
86003 1.5% 75,687 $1.64M
86480 1.5% 43,554 $1.63M
86803 1.5% 172,482 $1.61M
83036 Hemoglobin; glycosylated (A1C) 1.4% 297,065 $1.58M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.4% 64,331 $1.49M
36415 Collection of venous blood by venipuncture 1.3% 642,462 $1.42M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1.3% 131,186 $1.39M
80081 1.3% 26,975 $1.38M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1.2% 54,890 $1.31M
82728 1.2% 158,748 $1.29M
87086 Culture, bacterial; quantitative colony count, urine 1.1% 221,015 $1.22M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1.1% 63,356 $1.18M
87902 1.0% 6,802 $1.13M
83013 1.0% 23,537 $1.09M
82607 <1% 103,548 $915K
87088 <1% 173,123 $906K
84403 <1% 55,456 $873K
87522 Neg quan hep c or qual rna <1% 30,351 $868K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 48,397 $813K
84439 <1% 123,630 $679K
87510 <1% 48,441 $665K
87480 <1% 48,491 $664K
82746 <1% 76,039 $653K
87660 <1% 48,478 $645K
87799 <1% 27,754 $617K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 1,738 $600K
87536 <1% 10,282 $570K
87340 <1% 84,782 $568K
83550 <1% 105,454 $551K
86780 <1% 55,719 $501K
84702 <1% 48,262 $489K
82670 <1% 28,150 $476K
87070 <1% 80,873 $472K
86235 <1% 9,694 $461K
84481 <1% 45,749 $448K
87186 <1% 79,948 $446K
83540 <1% 109,042 $427K
85027 <1% 110,558 $423K
80074 <1% 15,607 $406K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 7,778 $398K
81513 <1% 27,915 $397K
87077 <1% 75,760 $395K
80048 Basic metabolic panel (calcium, ionized) <1% 81,556 $394K
84153 <1% 36,530 $377K
86704 <1% 44,481 $344K
83970 <1% 15,502 $338K
83001 <1% 27,062 $322K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 3,092 $319K
83880 <1% 14,821 $314K
87512 <1% 10,877 $308K
84402 <1% 18,108 $277K
84146 <1% 22,217 $275K
82570 <1% 90,343 $275K
86038 <1% 33,947 $269K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 1,616 $266K
86708 <1% 32,994 $265K
86364 <1% 10,414 $250K
83002 <1% 20,473 $245K
86696 <1% 18,770 $245K
86317 <1% 25,665 $243K
83516 <1% 30,710 $241K
82043 <1% 69,469 $240K
86706 <1% 34,329 $238K
86140 <1% 69,872 $237K
84270 <1% 16,556 $236K
86592 <1% 82,491 $234K
88142 <1% 17,328 $234K
87081 <1% 46,322 $229K
82105 <1% 19,918 $224K
86376 <1% 21,353 $204K
87631 <1% 2,627 $204K
84144 <1% 16,067 $200K
86762 <1% 20,137 $198K
82784 <1% 25,631 $192K
86787 <1% 19,541 $185K
82785 <1% 16,203 $182K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 2,055 $181K
81001 <1% 85,707 $173K
83655 <1% 20,715 $171K
87209 <1% 13,699 $169K
83735 <1% 40,863 $165K
86695 <1% 17,512 $163K
86800 <1% 15,503 $161K
88141 <1% 11,051 $159K
87529 <1% 5,379 $159K
82627 <1% 10,346 $153K
80055 <1% 5,967 $150K
83520 <1% 14,717 $144K
86850 <1% 25,053 $142K
86200 <1% 16,115 $137K
82950 <1% 36,845 $129K
82677 <1% 6,764 $122K
83690 <1% 27,329 $121K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 5,499 $120K
80076 <1% 22,927 $116K
87147 <1% 29,314 $116K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,155 $115K
85652 <1% 63,887 $114K
82951 <1% 11,492 $109K
82533 <1% 10,258 $106K
87338 <1% 11,834 $106K
83993 <1% 8,563 $103K
86147 <1% 4,622 $100K
84436 <1% 27,256 $98K
86665 <1% 4,614 $96K
86258 <1% 2,039 $95K
87075 <1% 14,977 $94K
86146 <1% 4,274 $94K
86008 <1% 4,381 $94K
83525 <1% 12,435 $93K
86431 <1% 24,999 $92K
86360 <1% 2,971 $92K
82274 <1% 9,769 $91K
82652 <1% 7,782 $90K
83921 <1% 7,646 $88K
81596 <1% 3,604 $84K
87177 <1% 13,678 $84K
83090 <1% 7,970 $83K
86141 <1% 9,753 $82K
86160 <1% 5,772 $82K
82542 <1% 5,717 $81K
86769 <1% 3,028 $80K
85610 <1% 31,822 $79K
84480 <1% 11,825 $79K
80164 <1% 10,609 $78K
86336 <1% 6,813 $77K
87517 <1% 2,704 $75K
87427 <1% 9,641 $75K
84479 <1% 19,910 $74K
87255 <1% 3,272 $72K
84550 <1% 25,840 $72K
87481 <1% 2,594 $69K
84154 <1% 6,609 $68K
84425 <1% 5,287 $68K
84445 <1% 2,068 $67K
86039 <1% 9,076 $66K
87449 <1% 8,918 $64K
86765 <1% 7,273 $63K
87045 <1% 9,983 $63K
80178 <1% 15,969 $63K
87205 <1% 22,536 $63K
83521 <1% 1,130 $63K
82653 <1% 957 $62K
83498 <1% 3,303 $61K
86361 <1% 3,434 $60K
86735 <1% 6,486 $58K
86225 <1% 6,325 $56K
86812 <1% 3,495 $55K
85060 <1% 6,194 $55K
87493 <1% 2,300 $54K
82977 <1% 12,417 $54K
82150 <1% 12,315 $52K
82024 <1% 2,080 $52K
84681 <1% 3,961 $52K
86255 <1% 7,325 $51K
84156 <1% 21,359 $51K
87329 <1% 6,190 $49K
82248 <1% 17,681 $49K
84207 <1% 2,605 $46K
82672 <1% 3,230 $45K
86900 <1% 21,840 $45K
86901 <1% 21,871 $45K
80069 <1% 9,736 $44K
86334 <1% 2,923 $42K
84165 <1% 6,003 $41K
82088 <1% 1,554 $41K
85730 <1% 11,460 $38K
86664 <1% 3,946 $38K
87046 <1% 5,796 $38K
82172 <1% 3,502 $38K
86705 <1% 4,773 $37K
82530 <1% 2,754 $37K
86870 <1% 1,460 $37K
82378 <1% 3,271 $37K
87324 <1% 4,869 $36K
84100 <1% 14,554 $36K
82247 <1% 12,576 $36K
87625 <1% 1,879 $36K
82550 <1% 8,812 $36K
81329 <1% 1,273 $35K
82140 <1% 4,078 $35K
84305 <1% 2,460 $35K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 629 $34K
81511 <1% 1,130 $34K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 466 $33K
86381 <1% 1,171 $33K
87563 <1% 1,786 $33K
82565 <1% 11,430 $33K
83721 <1% 7,780 $33K
86231 <1% 1,980 $32K
84630 <1% 4,457 $32K
86341 <1% 3,064 $31K
84460 <1% 9,578 $31K
84703 <1% 6,054 $30K
84482 <1% 2,775 $29K
86304 <1% 2,351 $28K
85007 <1% 12,078 $28K
82330 <1% 3,353 $28K
83615 <1% 7,152 $27K
80175 <1% 3,193 $27K
86162 <1% 1,936 $27K
82040 <1% 8,336 $26K
85379 <1% 3,983 $26K
85045 <1% 9,341 $26K
83519 <1% 2,552 $25K
83704 <1% 1,706 $25K
84450 <1% 7,090 $24K
36416 <1% 5,592 $24K
83020 <1% 2,573 $24K
99001 <1% 16,455 $23K
86036 <1% 1,022 $23K
82525 <1% 2,871 $23K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 248 $23K
87076 <1% 3,456 $22K
85246 <1% 1,417 $22K
86021 <1% 2,332 $22K
82952 <1% 7,134 $22K
84244 <1% 1,512 $21K
85018 <1% 13,433 $21K
82390 <1% 2,856 $20K
80197 <1% 2,390 $19K
85240 <1% 1,595 $19K
85245 <1% 1,234 $19K
86709 <1% 2,702 $19K
83630 <1% 1,481 $19K
86300 <1% 1,370 $18K
86015 <1% 1,326 $18K
80159 <1% 1,638 $18K
81241 <1% 570 $18K
80177 <1% 2,097 $18K
82947 <1% 7,127 $17K
99199 Unlisted special service, procedure or report <1% 27,727 $17K
83014 <1% 3,085 $17K
85014 <1% 10,308 $16K
87800 <1% 805 $16K
87535 <1% 752 $16K
83835 <1% 1,400 $16K
81015 <1% 7,442 $15K
82310 <1% 5,264 $15K
88342 <1% 389 $15K
86618 <1% 1,264 $14K
80156 <1% 1,919 $14K
82103 <1% 1,556 $13K
83695 <1% 2,910 $13K
84432 <1% 1,280 $13K
83698 <1% 859 $13K
81381 <1% 196 $13K
81025 <1% 2,562 $13K
84484 <1% 1,690 $13K
86359 <1% 605 $13K
85613 <1% 1,920 $13K
87901 <1% 72 $12K
86308 <1% 3,462 $12K
86645 <1% 1,101 $12K
86593 <1% 4,049 $12K
86644 <1% 1,224 $12K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 42 $11K
84166 <1% 937 $11K
86301 <1% 967 $11K
84155 <1% 5,192 $11K
82397 <1% 1,077 $11K
84520 <1% 4,699 $11K
83021 <1% 843 $11K
87328 <1% 1,274 $11K
84466 <1% 1,240 $10K
83883 <1% 1,312 $10K
86001 <1% 1,272 $10K
82626 <1% 518 $10K
81256 <1% 316 $9K
87150 <1% 8,840 $9K
80299 <1% 885 $9K
86663 <1% 1,061 $9K
83718 <1% 1,900 $9K
82668 <1% 762 $9K
84075 <1% 3,003 $9K
82465 <1% 3,337 $9K
84590 <1% 1,121 $9K
81512 <1% 303 $9K
82787 <1% 568 $9K
87101 <1% 1,711 $9K
84134 <1% 875 $8K
86628 <1% 362 $8K
87272 <1% 968 $8K
86682 <1% 1,118 $8K
87634 <1% 219 $7K
85049 <1% 2,235 $7K
85041 <1% 3,568 $7K
83010 <1% 889 $7K
87040 <1% 1,019 $7K
87521 Neg quan hep c or qual rna <1% 269 $7K
85247 <1% 449 $7K
84132 <1% 2,349 $7K
82747 <1% 684 $7K
80185 <1% 978 $6K
81003 <1% 4,512 $6K
80051 <1% 1,467 $6K
83825 <1% 560 $6K
87900 <1% 72 $6K
86753 <1% 605 $6K
85004 <1% 1,603 $6K
81291 <1% 772 $6K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 143 $5K
84478 <1% 1,458 $5K
82679 <1% 316 $5K
87140 <1% 817 $5K
81270 <1% 104 $5K
82671 <1% 209 $4K
84163 <1% 331 $4K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 132 $4K
0001M <1% 452 $4K
87102 <1% 738 $4K
85306 <1% 395 $4K
82166 <1% 168 $4K
84446 <1% 441 $4K
81206 <1% 50 $4K
87185 <1% 1,204 $4K
82175 <1% 312 $4K
81243 <1% 154 $4K
87254 <1% 204 $4K
86702 <1% 500 $3K
82164 <1% 358 $3K
86774 <1% 344 $3K
82384 <1% 193 $3K
85048 <1% 2,102 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 321 $3K
81240 <1% 115 $3K
85303 <1% 291 $3K
82085 <1% 423 $3K
88185 <1% 25 $3K
86337 <1% 178 $3K
84300 <1% 859 $3K
86777 <1% 259 $2K
84255 <1% 145 $2K
87015 <1% 549 $2K
87350 <1% 315 $2K
86701 <1% 499 $2K
87506 <1% 14 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 123 $2K
82340 <1% 593 $2K
82705 <1% 631 $2K
84260 <1% 91 $2K
87632 <1% 14 $2K
84295 <1% 710 $2K
86648 <1% 180 $2K
87999 <1% 84 $2K
86778 <1% 170 $2K
80183 <1% 247 $2K
83497 <1% 173 $2K
87206 <1% 408 $2K
86707 <1% 197 $2K
86382 <1% 95 $1K
85300 <1% 174 $1K
81443 <1% 14 $1K
87906 <1% 14 $1K
86256 <1% 130 $1K
82365 <1% 143 $1K
82656 <1% 148 $1K
82239 <1% 103 $1K
83935 <1% 234 $1K
87280 <1% 114 $1K
87220 <1% 363 $1K
83918 <1% 78 $1K
82157 <1% 55 $1K
85651 <1% 668 $986.09
82104 <1% 99 $971.63
88230 <1% 12 $883.84
84311 <1% 245 $863.02
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 1,897 $841.14
87503 <1% 95 $824.25
88262 <1% 12 $821.63
82553 <1% 109 $797.66
81350 <1% 42 $749.75
82107 <1% 28 $727.54
80201 <1% 89 $726.90
89055 <1% 224 $673.51
88184 <1% 25 $637.12
80203 <1% 63 $630.58
83930 <1% 135 $629.32
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 861 $616.08
82731 <1% 12 $596.70
84252 <1% 44 $580.33
84597 <1% 62 $578.91
88304 <1% 26 $561.15
86316 <1% 38 $549.18
82435 <1% 255 $527.54
86041 <1% 13 $524.62
82374 <1% 208 $472.10
82610 <1% 37 $455.45
82978 <1% 43 $424.92
86060 <1% 100 $422.61
81479 Unlisted molecular pathology procedure <1% 108 $415.47
87109 <1% 116 $393.02
86880 <1% 110 $372.60
80165 <1% 132 $362.43
82495 <1% 28 $354.75
84591 <1% 92 $341.42
81508 <1% 13 $325.84
85597 <1% 27 $317.24
85384 <1% 53 $302.83
86611 <1% 41 $298.13
86148 <1% 32 $290.20
86335 <1% 13 $274.93
87106 <1% 46 $263.92
86738 <1% 13 $236.20
80162 <1% 40 $216.07
86671 <1% 24 $216.07
82726 <1% 13 $189.00
82725 <1% 13 $176.80
85660 <1% 52 $171.23
87116 <1% 19 $154.63
81227 <1% 42 $153.90
86905 <1% 55 $140.30
81226 <1% 42 $137.88
81335 <1% 43 $116.59
81306 <1% 42 $105.33
87425 <1% 12 $100.57
81247 <1% 42 $100.35
82955 <1% 14 $97.96
84087 <1% 24 $96.18
81225 <1% 42 $90.00
83992 <1% 35 $88.11
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 98 $72.36
81283 <1% 42 $65.07
80324 <1% 1,070 $62.64
89051 <1% 12 $54.22
87184 <1% 12 $48.22
G0475 Hiv antigen/antibody, combination assay, screening <1% 1,411 $44.57
80354 <1% 1,113 $42.00
80348 <1% 517 $39.10
84133 <1% 12 $36.11
80323 <1% 214 $33.94
80358 <1% 1,184 $32.79
80349 <1% 1,819 $12.08
80337 <1% 34 $3.78
80370 <1% 34 $3.46
80365 <1% 1,155 $3.39
80361 <1% 1,176 $3.39
80356 <1% 72 $3.39
80326 <1% 34 $3.25
80346 <1% 1,077 $3.22
80360 <1% 140 $3.15
80338 <1% 34 $3.15
80321 <1% 196 $3.15
80368 <1% 34 $3.15
80377 <1% 34 $2.18
80345 <1% 50 $2.00
80320 <1% 56 $1.89
81232 0% 42 $0.00
81355 0% 42 $0.00
80355 0% 19 $0.00
80375 0% 455 $0.00
80373 0% 112 $0.00
80364 0% 461 $0.00
80366 0% 19 $0.00
80369 0% 14 $0.00
81328 0% 42 $0.00
80372 0% 19 $0.00
80344 0% 19 $0.00
80371 0% 441 $0.00
80352 0% 441 $0.00
81230 0% 42 $0.00
80329 0% 12 $0.00
81231 0% 42 $0.00
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 0% 37 $0.00
81400 0% 42 $0.00
85008 0% 72 $0.00
80353 0% 19 $0.00
80333 0% 19 $0.00
80359 0% 19 $0.00
80357 0% 19 $0.00
80330 0% 19 $0.00
80367 0% 19 $0.00
80340 0% 19 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBOWLES, CHARLES (VICE PRESIDENT)
Parent organizationQUEST DIAGNOSTICS INCORPORATED
Same official

Other billing entities under BOWLES, CHARLES

Full network →
ProviderLocationPaid
Quest Diagnostics LLCMarlborough, MA$209.74M
Quest Diagnostics of Pennsylvania, INC.Pittsburgh, PA$132.39M
Quest Diagnostics Clinical Laboratories INCPortland, OR$21.85M
Quest Diagnostics of Pennsylvania INC.Buffalo, NY$20.20M
Quest Diagnostics Clinical Laboratories INCCollegeville, PA$12.52M
Solstas Lab Partners Group LLCGreensboro, NC$11.62M
Quest Diagnostics Incorporated MiFlint, MI$8.64M
Quest Diagnostics Clinical Laboratories INCTucker, GA$3.66M
Unilab CorporationWest Hills, CA$3.12M
Quest Diagnostics of Pennsylvania INC.Twinsburg, OH$2.56M
Quest Diagnostics Incorporated MDFalls Church, VA$936K
Quest Diagnostics LLCWallingford, CT$706K
Quest Diagnostics of Pennsylvania INC.North Syracuse, NY$492K
Solstas Lab Partners, LLCKnoxville, TN$455K
Quest Diagnostics Clinical Laboratories INCNorristown, PA$319K
Unilab CorporationSan Jose, CA$253K
Unilab CorporationOrange, CA$122K
Quest Diagnostics LLCStratford, CT$103K
Unilab CorporationBakersfield, CA$53K
Quest Diagnostics Clinical Laboratories INCHorsham, PA$48K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.